Drug intelligence / Profile preview

oxycodone + acetaminophen (Forte Bio-Pharma)

Development stage
Unknown
Lead developer
Forte BioPharma
Modality
Small Molecules
Administration
Oral
01

Overview

Prolate OS is an FDA-approved oral solution formulation of oxycodone hydrochloride and acetaminophen, developed by Forte BioPharma. It is indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. Oxycodone acts as a mu-opioid receptor agonist, providing potent analgesia through the central nervous system, while acetaminophen provides non-opioid analgesia and antipyretic effects, likely through the inhibition of cyclooxygenase enzymes. As an opioid-containing product, Prolate OS is subject to the FDA's Opioid Analgesic Risk Evaluation and Mitigation Strategy (REMS) program due to the significant risks of addiction, abuse, misuse, and potentially fatal respiratory depression.

Brand names
Prolate OSProlate
Other names
oxycodone hydrochloride and acetaminophen oral solution
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)MOR (Mu opioid receptor)DOR (Opioid Receptor Delta 1)PGHS-1 (Prostaglandin G/H Synthase 1)KOR (Kappa opioid receptor)

Beyond the preview

Go deeper on oxycodone + acetaminophen (Forte Bio-Pharma).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on oxycodone + acetaminophen (Forte Bio-Pharma).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call